Kesselring will work with the MAPS Professional Development Committee to assist with the creation of courses supporting 7 Medical Affairs competency certification tracks identified in the MAPS 5-year strategic plan.
This white paper addresses insights challenges in Strategy, Data Generation, and Analysis/Reporting – arming Medical Affairs teams with the tools and opportunity to build strategies that preempt these challenges.
This paper provides a vision describing how Gen AI technologies will reshape the possibilities and practice of Medical Affairs related to the four functional pillars of Strategy & Leadership, Evidence & Insights Generation, Evidence & Insights Communication, and Engagement & Partnerships.
This article highlights a collaborative approach to content creation in which insights from MSLs were used to develop concepts for educational tools that were shared with key opinion leaders (KOLs).
This white paper by the MAPS Field Medical FAWG details strategies for optimizing your Field Medical team for the OmniChannel World
This white paper by the MAPS Medical Communications FAWG details strategies for using modular content to increase the efficiency and accuracy of medical and scientific content to enable omnichannel engagement strategy.
The growth of Real-World Evidence (RWE) from sources including patient registries, claims data, electronic medical records, digital health technologies and more has powered the ability of Medical Affairs to drive patient outcomes. Here, the MAPS Executive Consortium describes how.
MAPS is pleased to share our 2023 Medical Metrics Benchmarking Report, based on findings from 51 leading organizations representing the Pharmaceutical, Biotech, and Medical and Diagnostic Device sectors.
As evidence generation becomes more advanced and integrated into Medical Affairs strategic plans, there is a greater need to maximize its impact by leveraging emerging digital technologies to communicate complex clinical and nonclinical data.
MAPS announces the election of Dr. Danie du Plessis as Chair of the MAPS Board of Directors. Du Plessis is currently Executive Vice-President (EVP) & Head of Medical Affairs at Kyowa Kirin International and is a senior pharmaceutical executive with 30 years’ experience.